Immuron (IMRN) Other Accumulated Expenses (2019 - 2025)
Immuron (IMRN) recorded quarterly Other Accumulated Expenses of $452.72 in Q3 2025, down 98.4% quarter-over-quarter from $28239.2 in Q4 2024, and up 11.63% on a YoY basis from $405.56 in Q3 2024.
Immuron (IMRN) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Immuron's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $452.72 for Q3 2025.
- In Q3 2025, Other Accumulated Expenses rose 11.63% year-over-year to $452.72; the TTM figure through Sep 2025 stood at $452.72 (up 11.63% YoY), while the FY2025 annual figure was $452.72, up 11.63% from the prior year.
- Other Accumulated Expenses was $452.72 for Q3 2025 at Immuron, down from $28239.2 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $28239.2 in Q4 2024 to a low of $246.22 in Q2 2022.
- Historically, Other Accumulated Expenses has averaged $12585.6 across 5 years, with a median of $15004.9 in 2021.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses sank 98.86% in 2023, then surged 10839.86% in 2024.
- A 5-year view of Other Accumulated Expenses shows it stood at $15004.9 in 2021, then surged by 50.52% to $22585.8 in 2022, then tumbled by 98.86% to $258.13 in 2023, then soared by 10839.86% to $28239.2 in 2024, then plunged by 98.4% to $452.72 in 2025.
- The last three Other Accumulated Expenses figures came in at $452.72 (Q3 2025), $28239.2 (Q4 2024), and $405.56 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 452.72 |
| Dec 31, 2024 | 28,239.15 |
| Sep 9, 2024 | 405.56 |
| Jun 30, 2024 | 26,727.40 |
| Dec 31, 2023 | 258.13 |
| Sep 28, 2023 | 25,410.98 |
| Aug 30, 2023 | 387.67 |
| Jun 30, 2023 | 259.10 |
| Dec 31, 2022 | 22,585.78 |
| Aug 31, 2022 | 23,905.86 |
| Jun 30, 2022 | 246.22 |
| Dec 31, 2021 | 15,004.91 |
| Jun 30, 2021 | 19,729.58 |
| Dec 31, 2020 | 415.45 |
| Sep 1, 2020 | 42,176.00 |
| Dec 31, 2019 | 421.76 |